Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 15, 2005 (Vol. 25, No. 6)

Genome.gov | National Human Genome Research Institute

  • News, Links
  • None
How can it be that this site escaped my radar until now? It certainly hasn’t been for my lack of scouring the Web. Perhaps the site is not linked as extensively as one might guess for such a catchy title that is housed at an NIH institute (the National Human Genome Research Institute). The opening page covers topics all over the map, but that isn’t bad, considering genome information is popping up almost everywhere and being used almost everywhere else. Headlines I visited included news of the dog genome and reconstruction of the DNA of a dinosaur-era creature. Topic areas included health, grants, policy, education, careers, and links to seminars and short course on genome analysis. There is literally something here for every molecular biologist.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »